News

A recent study has found that 1 in 9 men living in the United States have oral HPV.

Dr. Shibani Mukerji discusses how HIV affects the brain as part of a symposium at ID Week 2017.

A new article details how researchers are working to develop a universal flu shot.

While the northern hemisphere moves into fall, individuals in southern states must remain vigilant about Zika virus prevention.

According to reports in multiple media outlets, clinicians on the hurricane-ravaged island have already identified at least 10 cases of a rare water-borne bacterial infection, and they warn of the potential for more.

A new literature review of 60 papers and studies finds that voluntary medical male circumcision programs in Africa also have benefits for women’s health.

The pneumonic plague outbreak in Madagascar infects 684 individuals and claims 57 lives, thus far. Has it spread to Seychelles?

New research supports that allergy evaluation is an inexpensive intervention and that given the downstream benefits, it may well be cost-effective.

NIAID director Dr. Anthony S. Fauci stresses in a recent commentary that, from a practical standpoint, the development of a moderately effective HIV vaccine is “essential” to ending the pandemic.

A total of 5 HIV cure research initiatives will receive $7.5 million as recipients of Gilead’s HIV cure grants program.

Researchers in a pediatric hospital in Tokyo see positive results following the implementation of an antibiotic stewardship program limiting carbapenem use.

The declaration was made to help direct funds towards controlling the outbreak and providing adult hepatitis A vaccines to those in need.

Recent research reveals that the composition of a woman’s vaginal microbial makeup—specifically, a preponderance of the bacteria Lactobacillus iners—may mean she’s more likely to be infected with Chlamydia trachomatis.

New tests continue to evolve that offer greater sensitivity than current methods.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Dr. Daniel Lucey provided insight on past and current yellow fever outbreaks and vaccine shortages at ID Week 2017; he also cited the very real possibility of yellow fever hitting Asia.

Researchers from the University of Colorado Boulder have developed nanoparticles capable of boosting the effectiveness of antibiotics against drug-resistant superbugs.

A recent outbreak involving sterile medical supplies gives insight into a new hospital infectious disease threat.

In any differential diagnosis of microcephaly, clinicians should consider other infections as well, depending on the setting and history of the patient.

Results from a randomized, double-blind, placebo-controlled trial show that letermovir protects from viral infection in CMV-seropositive individuals following allogeneic hematopoietic cell transplantation.

IDSA and HIVMA urge Congress to approve emergency funding for hurricane response efforts in Puerto Rico and the US Virgin Islands and to prevent future public health crises.

The ambitious goal of global elimination of the virus by 2030 will take buy-in from all major stakeholders, including the United States.

Presenters combed through the barrage of clinical trials to share those that could be practice-changing for clinicians.

Flu season has officially begun in the United States, as the first cases and deaths of the season are reported, prompting health officials to press for vaccination.

One survey found that fewer than 60% of 18- to 24-year-olds regularly use condoms during sexual encounters.

A new study pulls back the curtain into a complex web of resistance, colonization, and the challenges of antimicrobial resistance in this setting.

Why is delafloxacin unique compared to other fluoroquinolones? Find out more.

A recent study found that a sepsis care bundle program implemented in The Mount Sinai Hospital in New York coincided with an increase in antibiotic prescriptions and higher rates of Clostridium difficile infections.